CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma

Jong-Yun Woo, Seung Ho Yang, Youn Soo Lee, Su Youn Lee, Jeana Kim, Yong Kil Hong

Journal of Korean Neurosurgical Society. 2015;58(5):426-431. Published online 2015 November 30 DOI: https://doi.org/10.3340/jkns.2015.58.5.426

Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma

Jong-Yun Woo, Seung Ho Yang, Youn Soo Lee, Su Youn Lee, Jeana Kim, Yong Kil Hong

Journal of Korean Neurosurgical Society. 2015;58(5):426

Link1

Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma

Florian Stockhammer, Martin Misch, Arend Koch, Marcus Czabanka, Michail Plotkin, Cristiane Blechschmidt, Jochen Tuettenberg, Peter Vajkoczy

Journal of Neuro-Oncology. 2010;100(3):407-415

Link1

Link2 Link3

Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib

Marcel Seiz, Ingo Nölte, Ioannis Pechlivanis, Christian F. Freyschlag, Kirsten Schmieder, Peter Vajkoczy, Jochen Tuettenberg

Neurosurgical Review. 2010;33(3):375-381

Link1

Link2 Link3

UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma

Ulrich Herrlinger, Johannes Rieger, Joachim P. Steinbach, Thomas N�gele, Johannes Dichgans, Michael Weller

Journal of Neuro-Oncology. 2005;71(3):295-299

Link1

Link2 Link3

Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme

Marc C. Chamberlain, Denice D. Tsao-Wei

Cancer. 2004;100(6):1213-1220

Link1 Link2

‘Low-Dose Metronomic Temozolomide’ in Recurrent Tmz-Refractory Glioblastoma Patients: a Retrospective Analysis of National Data in Korea

Y. Choi, M.S. Yun, S.H. Lim, S. Bae, Y. Na, Y.H. Kim, K.S. Kang, S. Lee

Annals of Oncology. 2014;25:iv141

Link1 Link2 Link3

Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients

Paola Gaviani, A. Salmaggi, A. Silvani

Journal of Neuro-Oncology. 2011;104(2):617-618

Link1

Link2 Link3

A phase II clinical trial evaluating the efficacy and safety of apatinib combined with dose-dense temozolomide in recurrent glioblastoma

Y. Wang, R. Tao

Annals of Oncology. 2019;30:v155

Link1 Link2 Link3

Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study

Jeffrey Greenspoon, Waseem Sharieff, Holger Hirte, Andrew Overholt, Rocco DeVillers, Thorsteinn Gunnarsson, Anthony Whitton

OncoTargets and Therapy. 2014;485

Link1

Molecular mechanisms in temozolomide-resistant glioblastoma

Sang Y. Lee, Gaspar J. Kitange

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. 2021;79-133

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Korean Neurosurg Soc has participated in CrossRef Text and Data Mining service since March 1, 2015.